Discover a vaccine near you: Examine your health department:
Influenza (Influenza) and COVID-19 are both infectious breathing illnesses, however they are brought on by different viruses. COVID-19 is brought on by infection with a brand-new coronavirus (called SARS-Co, V-2), and flu is triggered by infection with influenza infections. COVID-19 appears to spread more quickly than flu and causes more severe health problems in some people. It can also take longer prior to individuals show symptoms and individuals can be contagious for longer. More details about differences between influenza and COVID-19 is readily available in the various sections listed below. Due to the fact that some of the symptoms of flu and COVID-19 are comparable, it might be hard to discriminate in between them based upon symptoms alone, and screening may be needed to assist verify a medical diagnosis.
This page compares COVID-19 and flu, given the finest offered information to date.
Coronavirus illness (COVID-19) is an infectious illness triggered by a freshly found coronavirus. Most individuals contaminated with the COVID-19 infection will experience moderate to moderate respiratory disease and recuperate without needing unique treatment. Older individuals, and those with underlying medical issues like cardiovascular disease, diabetes, persistent breathing illness, and cancer are more most likely to develop serious health problem. The finest way to avoid and slow down transmission is to be well informed about the COVID-19 virus, the illness it triggers and how it spreads out. Protect yourself and others from infection by cleaning your hands or using an alcohol based rub regularly and not touching your face.
Like this short article This article has: 8 overall likes. Share this.
Scientists at the Texas A&M University Global Health Research Study Complex (GHRC) have determined a variation of the COVID-19 virus "BV-1" that might present a brand-new challenge to public health. Although found in just one person who had just moderate signs, the Texas A&M researchers decided they should share information about the variant with scientists around the world. That's since released cell culture-based experiments from other labs have actually revealed a number of neutralizing antibodies are inefficient in managing other variants with the very same hereditary markers as BV-1. "We do not at present know the complete significance of this version, however it has a combination of mutations comparable to other internationally notifiable variations of issue," said GHRC Chief Virologist Ben Neuman.